| Q38565751 | EDA-ID and IP, two faces of the same coin: how the same IKBKG/NEMO mutation affecting the NF-κB pathway can cause immunodeficiency and/or inflammation |
| Q37863509 | Educational paper. The expanding clinical and immunological spectrum of severe combined immunodeficiency |
| Q36698269 | Evaluating risks of insertional mutagenesis by DNA transposons in gene therapy |
| Q37858878 | Ex vivo gene transfer and correction for cell-based therapies |
| Q35946132 | Expansion of somatically reverted memory CD8+ T cells in patients with X-linked lymphoproliferative disease caused by selective pressure from Epstein-Barr virus. |
| Q36397956 | Extensive genetic variation in somatic human tissues |
| Q27499229 | Genetics of SCID |
| Q36059501 | Genomic Copy Number Variation Affecting Genes Involved in the Cell Cycle Pathway: Implications for Somatic Mosaicism |
| Q61632990 | Human hyper-IgE syndrome: singular or plural? |
| Q38235840 | Inborn errors of metabolism underlying primary immunodeficiencies |
| Q30409845 | Intravenous injection of a foamy virus vector to correct canine SCID-X1. |
| Q36303058 | Omenn syndrome associated with a functional reversion due to a somatic second-site mutation in CARD11 deficiency |
| Q36808097 | Partial defects of T-cell development associated with poor T-cell function |
| Q37602522 | Progress and prospects: gene therapy for inherited immunodeficiencies |
| Q41437749 | RAG1 reversion mosaicism in a patient with Omenn syndrome |
| Q36281144 | Revertant mosaicism for family mutations is not observed in BRCA1/2 phenocopies |
| Q28741264 | Revertant mosaicism in skin: natural gene therapy |
| Q59335239 | Somatic alterations compromised molecular diagnosis of DOCK8 hyper-IgE syndrome caused by a novel intronic splice site mutation |
| Q34479594 | Somatic genome variations in health and disease |
| Q35284944 | Somatic mosaicism caused by monoallelic reversion of a mutation in T cells of a patient with ADA-SCID and the effects of enzyme replacement therapy on the revertant phenotype |
| Q34042360 | Somatic reversion in dedicator of cytokinesis 8 immunodeficiency modulates disease phenotype |
| Q62658169 | T-cell defects in patients with germline mutations account for combined immunodeficiency |
| Q30235895 | The genomics of inherited bone marrow failure: from mechanism to the clinic. |
| Q38119245 | The long and winding road that leads to a cure for epidermolysis bullosa. |
| Q37247526 | Updates and future horizons on the understanding, diagnosis, and treatment of Sturge-Weber syndrome brain involvement |
| Q59443482 | Wake-up Sleepy Gene: Reactivating Fetal Globin for β-Hemoglobinopathies |
| Q47097066 | Whole-exome sequencing for detecting inborn errors of immunity: overview and perspectives. |
| Q38236177 | XLP: clinical features and molecular etiology due to mutations in SH2D1A encoding SAP. |
| Q54694891 | [Wiskott-Aldrich syndrome with special phenotypes: report of 3 cases]. |